@OopsGuess One underappreciated effect of restrictions is that they change incentives. When imports become unreliable, local firms suddenly have a compelling business case to build alternatives that previously wouldn’t have attracted the same investment.
It’s time to take back control.
- Stocks, options & prediction markets
- An AI advisor that works for you
- Agents that can finally use Coinbase
https://t.co/c0HqFKO5QV
@ChrisRMcGuire Hard to ignore: the loudest voices defending restrictions in one part of the AI stack become deeply concerned when similar restrictions affect another part. If broad controls are bad for frontier models, it’s worth asking whether broad controls elsewhere deserve the same scrutiny
@zephyr_z9 The real strategic asset isn’t a single technology, it’s becoming the foundation everyone else builds on. Once customers start redesigning supply chains around alternatives, those decisions can outlive the policy that triggered them.
@profstonge The goal shouldn’t be maximizing sales to China or maximizing restrictions. The goal should be preserving U.S. technological leadership. The question is whether current policies are achieving that.
@derek_debus when it comes to taking care of our veterans who actually did the work, the VA system is almost impossible to navigate. That’s why they need guidance and insight from those who truly know the system, like private companies, to help them get the ratings they’ve earned.
$SRPT
Elevidys is approved and delivering real benefits for DMD boys. With ongoing research into redosing and better dystrophin, the future looks brighter. DMD families are warriors, hope keeps growing stronger every day!
🚨🚨 FBI HAS WARNED POLICE DEPARTMENTS IN CALIFORNIA THAT IRAN WANTS TO RETALIATE FOR AMERICAN ATTACKS BY LAUNCHING OFFENSIVE DRONES AGAINST THE WEST COAST -ABC NEWS
$SRPT
Johnson's the same guy who jumped in to save Elevidys access when they tried to yank it. Company's still standing, Elevidys helping kids move better long term, and now Huntington siRNA in the pipe. Feels like political pressure might actually do something useful for once.
Elevidys is saving time for DMD families every day, slowing progression, improving function. Doug steps away leaving $SRPT financially strong, scientifically advanced, and fully committed. The future of gene therapy for rare diseases looks brighter because of Sarepta!